Osteri 750mcg

Osteri 750mcg injection contains Teriparatide as its active ingredient. This synthetic form of parathyroid hormone (PTH), which is naturally produced by the parathyroid glands, is used to treat osteoporosis. Osteoporosis is characterized by weakened bones, which increases the risk of fractures. Such fractures can significantly diminish a person’s quality of life, leading to pain and limited mobility.

The Osteri 750mcg injection works by stimulating the formation of new bone tissue and improving bone mineral density. Research indicates that this medication can speed up the healing process for individuals with fractures. It aids in the development of callus, the initial structure of new bone that forms during healing, resulting in quicker and more effective recovery.

Patients with known hypersensitivity or allergic reactions to Osteri 750mcg injection or any of its ingredients should refrain from using this medication. It is also contraindicated for those with a history of skeletal cancers, such as osteosarcoma, or individuals with bone metastases. Furthermore, if a patient has undergone previous radiation therapy affecting the skeleton, the use of this medication is not recommended due to the potential risk of developing osteosarcoma.